首页 | 官方网站   微博 | 高级检索  
     

p53基因codon 72多态性与乳腺癌的相关性研究*
引用本文:周晓颖,张丽娜,赵妍蕊,郑红,陈可欣.p53基因codon 72多态性与乳腺癌的相关性研究*[J].中国肿瘤临床,2010,37(9):499-503.
作者姓名:周晓颖  张丽娜  赵妍蕊  郑红  陈可欣
作者单位:作者单位:乳腺癌防治教育部重点实验室,天津市肿瘤防治重点实验室,天津医科大学附属肿瘤医院肿瘤流行病与生物统计学研究室(天津市 300060)
基金项目:国家自然科学基金资助 
摘    要:目的:研究p53基因codon 72 多态性与乳腺癌患者的年龄、病理分期、淋巴结转移、雌激素受体(ER)、孕激素受体(PR)、c-erbB-2、P53蛋白表达情况的相关性。方法:TaqMan探针方法检测277 例乳腺癌患者血液标本的p53基因codon 72多态性。免疫组化SP法检测匹配肿瘤组织中ER、PR、c-erbB-2 和P53蛋白的表达情况。SPSS16.0 软件行统计学分析,p53基因多态性与病理学特征关系用χ2检验,非条件Logistic回归分析基因多态性与ER、PR、c-erbB-2、P53蛋白表达的相关性,计算OR值及其95% 可信区间(95% CI)。 P<0.05为差异有统计学意义。结果:p53基因codon 72基因型为CC/CG/GG,频率分别为22.0% 、51.3% 和26.7% ,携带CC、CG、GG基因型的患者发病年龄逐渐降低,但无统计学差异;p53基因codon 72多态性与临床病理学特征无关,与ER、PR、c-erbB-2 和P53蛋白表达无相关性(P>0.05)。 肿瘤组织P53蛋白表达与ER、PR、c-erbB-2 蛋白表达密切相关(χ2=13.492,P=0.000;χ2=3.970,P=0.046;χ2=17.956,P=0.000)。 结论:p53基因codon 72多态性与P53蛋白表达及病理学特征无相关性,P53蛋白表达与ER、PR、c-erbB-2 蛋白表达关系密切。p53基因codon 72基因型与患者发病年龄的关系有待扩大样本量进一步研究。 

关 键 词:p53codon  72    乳腺癌    免疫组化
收稿时间:2010-01-10

Study on p53 Codon 72 Polymorphism in 277 Patients with Breast Cancer
Affiliation:Department of Epidemiology and Biostatistics, Cancer Institute and Hospital of Tianjin Medical University, Tianjin 300060, China
Abstract:Objective: To investigate the correlation of p53codon 72polymorphism with clinicopathologic features of breast cancer patients including age, tumor staging, lymph node status, receptor status of estrogen and progestin, expres-sion of P 53protein and c-erbB- 2. Methods:Blood samples were collected from 277 women with primary breast cancer. Taq-Man was used to determine the genotypes of p53codon 72polymorphism. Expression of ER, PR, c-erbB- 2 and P 53pro-teins were detected with immunohistochemistry. SPSS 16.0 software was employed for statistical analysis and the relation -ship of p 53polymorphism with all of the clinicopathologic parameters was evaluated with χ2 test. Furthermore, the associa -tion of p 53polymorphism with ER, PR, c-erbB- 2 and P 53protein expression was analyzed by logistic regression analysis. Results: The frequency of CC, CG, and GG at p 53codon 72was 22.0%,51.3%, and26.7%, respectively. No correlation was found between genotype distribution and clinicopathologic parameters of disease outcome. There was no correlation between p 53condon 72polymorphisms and the expression of ER, PR, c-erbB-2, or P 53proteins (P>0.05). P 53protein ex-pression was associated with expression of ER, PR, and c-erbB-2 proteins (χ2=13.492 , P=0.000 ; χ2=3.970 , P=0.046 ; χ2=17.956 , P=0.000 ). Conclusion:There is no correlation between p53codon 72polymorphism and clinicopathologic parame -ters of breast cancer. P 53protein is significantly associated with ER, PR and c-erbB-2 expression. Further study using a larger sample is warranted. 
Keywords:p53  codon  72
本文献已被 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号